“Youth molecule” shows potential and results from new study show improvements in memory, mobility and metabolism. But there is still no consensus on supplements currently marketed
An international group of over 25 scientists revealed new discoveries about the They+also known as the “youth molecule” and the main ingredient of various market supplements.
The study, in Nature AgingIt brings together years of clinical trials and concludes that this compound may not only delay the effects of aging, but also offer additional protection against neurodegenerative diseases such as and affect tens of millions of people worldwide.
Nad+ (nicotinamide and adenine dinucleotide) plays an essential role in cell energy production, DNA repair and maintenance of cellular functions. But their levels naturally decrease with age, which is associated with memory loss, muscle weakening and the development of various diseases linked to aging.
According to the research authors, reinforcing NAD+ metabolism can delay health deterioration and mitigate premature aging pathologies.
Researcher Jianying Zhang of the University of Oslo stresses that this mechanism “may even be key to prolonging vitality and reducing risk of degenerative diseases,” quotes.
In essays, scientists explored different ways to increase NAD+levels. The most common strategies are the administration of vitamin -like compounds.
Os Preliminary results reveal improvements in memory, mobility and metabolism.
Along the academic investigation, it has grown rapidly, and around the world, the market of supplements NAD+. Despite the increasing demand, experts warn of the a lack of consensus As for the ideal form of use.
“There is still a lot of noise in the industry, with different supplements in the market and few conclusive data on which ones really work,” explains researcher Evandro Fei Fang-Stand.
The authors therefore argue that longer -scale and long -term studies are needed to evaluate appropriate doses, long -term effects and possible response variations between individuals.
